Yaacov Lawrence

Spezialisierung: Neuroonkologe/-in
31 Jahre der Erfahrung
Spricht:
English, Hebrew
Online-Konsultationen: verfügbar
Arbeitsplatz: Israel, Ramat Gan, Sheba Medizinisches Zentrum
Diese Ärztin/dieser Arzt ist Fellow der ASTRO (FASTRO), eine der höchsten Auszeichnungen in der Radioonkologie.
Dr. Yaacov Lawrence, MA, MBBS, MRCP, ist Leiter der Abteilung für Radioonkologie am Sheba Medical Center. Er verfügt über fast 30 Jahre Erfahrung in präzisionsorientierter Strahlentherapie und Neuroonkologie.

Er ist Experte für moderne Strahlentherapie und Radiochirurgie. Er führt stereotaktische Radiochirurgie bei Hirntumoren durch. Er leitet am Sheba das GI-Krebsprogramm (gastrointestinale Onkologie). Zudem bietet er präzisionsmedizinische Versorgung bei Lungen- und Prostatakrebs an. Er war Wegbereiter der Radiochirurgie des Zöliakusplexus zur Behandlung starker Schmerzen bei Bauchspeicheldrüsenkrebs.

Ausbildung und Qualifikationen: MA und MBBS (Cambridge und UCLH); MRCP (RCP); Fellowship in Radioonkologie (Thomas Jefferson University). Auszeichnungen u. a. ASCO Young Investigator Award und Fellow of ASTRO (FASTRO). Autor von über 280 Publikationen. Direktor des Zentrums für translationale Radioonkologie und außerordentlicher Professor an der Universität Tel Aviv.

Online-Konsultation bei Yaacov Lawrence

Bequem und einfach

100% sicher und vertraulich

$1,900

Dienstleistungen des Arztes

Wie läuft es für Sie mit uns?

1 von 3

Die Informationen über diesen Arzt sind vollständig und klar

Stimme nicht zu

Stimme stark zu

Qualifikationen

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He is a Fellow of ASTRO (FASTRO), an honor in radiation oncology. He specializes in precision radiation therapy and neuro-oncology for specific cancer cases.

Precision Radiation Oncology & Specialization

Dr. Lawrence uses radiation therapy to treat various malignant conditions. He achieves treatment outcomes for his patients while reducing side effects. The specialist performs stereotactic radiosurgery for brain tumors and intracranial lesions — a procedure that uses high doses of radiation to destroy tumor cells without traditional surgery.

He leads the GI Cancer Program at Sheba Medical Center for gastrointestinal oncology. Dr. Lawrence pioneered celiac plexus radiosurgery to treat severe pain from pancreatic cancer. This non-invasive technique helps patients manage symptoms of advanced abdominal diseases. Because the approach is non-invasive, patients avoid the risks of traditional surgical methods.

The doctor also provides care for lung and prostate cancers. He integrates translational research directly into clinical protocols to achieve personalized treatment. His methods include combining immunotherapy with targeted radiation doses. This combination helps the body's immune system recognize and attack cancer cells more effectively.

Academic & Leadership Roles

Chair of the Radiation Oncology Department at Sheba Medical Center
Director of the Center for Translational Radiation Oncology
Associate Professor at Tel Aviv University
Former Assistant Professor at Thomas Jefferson University

Education & Professional Training

MBBS – University College London Hospital (UCLH)
MA – University of Cambridge
Radiation Oncology Fellowship – Thomas Jefferson University
Member of the Royal College of Physicians (MRCP)

Scientific Contributions & Awards

Dr. Lawrence has authored over 280 scientific publications in international journals. His research focuses on biomarkers and personalized radiation therapy protocols. He also studies treatment strategies for cancers and nervous system tumors.

The doctor received the ASCO Young Investigator Award for his research contributions. This award recognizes early-career physicians for their work in clinical oncology research. He presents his findings on immunotherapy and radiation combinations at congresses. He develops next-generation radiation techniques to improve patient outcomes.

Professional Memberships

Fellow of the American Society for Radiation Oncology (FASTRO)
Member of the American Society of Clinical Oncology (ASCO)
Member of the Royal College of Physicians (RCP)